Company Analysis

Alpha Tau Medical Ltd. (DRTS)

Nasdaq: DRTS · Surgical & Medical Instruments & Apparatus · Jerusalem, IL · filing with the SEC since 2021
Grade5.4
◀ Past 6.1● Present 5.2▶ Future 5.1
7 est.
The companyfiscal 2025, as filed
Revenuen/a
Net income-$42.6M-34.3%
Earnings per share$-0.53-17.8%
Operating cash flow-$26.7M-34.9%
Cash$12.2M-11.1%
Debtn/a
Shareholders’ equity$77.1M+23.0%
Shares, diluted80.6M+15.2%
Return on equity-55.3%
The recordfrom its filings
Filings in 202668
Newest filingNov 12 · 6-K
Annual reportMar 9, 2026
Quarterly reportn/a
Next report due20-F by Apr 30
Insider sales, 12 months$1.6M
Insider buys, 12 months$0.00
Patents granted23
Filer categoryAccelerated filer<br>Emerging growth company
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
19202122232425
As filed, in USD. Nothing here is a forecast.

News

Aug 25, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Aug 12, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton DRTS · research, not advice